Actavis PLC, is a global, integrated specialty pharmaceutical company. The Company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company produces and markets generic, branded generic, branded and over-the-counter (OTC) pharmaceutical products covering all therapeutic classes. The Company's product formulations include modified release, solid oral dosage, semi-solids, suspensions, transdermals, suppositories, creams, ointments, liquids and injectables. In July 2014, the Company acquired Forest Laboratories, Inc. In July 2014, the Company acquired Furiex Pharmaceuticals, Inc. In July 2014, Impax Laboratories Inc acquired from Actavis plc two generic products.